Systemic therapy of cancer: facts and expectations
<p><strong>Background:</strong> Systemic therapy of cancer had its first major expansion in the second half of the 20th century with the development of chemotherapy and hormonal therapy. Some cancers, like leukemias, lymphomas, osteosarcoma and testicular cancer became highly curab...
Main Author: | Tanja Čufer |
---|---|
Format: | Article |
Language: | English |
Published: |
Slovenian Medical Association
2007-12-01
|
Series: | Zdravniški Vestnik |
Subjects: | |
Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/1932 |
Similar Items
-
Systemic Therapy for HER2-Positive Metastatic Breast Cancer: Current and Future Trends
by: Kreina Sharela Vega Cano, et al.
Published: (2022-12-01) -
HER2-Positive Gastric Cancer and Antibody Treatment: State of the Art and Future Developments
by: Magdalena K. Scheck, et al.
Published: (2024-03-01) -
Feasibility of HER2-Targeted Therapy in Advanced Biliary Tract Cancer: A Prospective Pilot Study of Trastuzumab Biosimilar in Combination with Gemcitabine Plus Cisplatin
by: Hyehyun Jeong, et al.
Published: (2021-01-01) -
Possibilities of therapeutic use of HER2-inhibitorsin metastatic colorectal cancer: a case report
by: A. A. Kachmazov, et al.
Published: (2019-12-01) -
Doxorubicin- and Trastuzumab-Modified Gold Nanoparticles as Potential Multimodal Agents for Targeted Therapy of HER2+ Cancers
by: Kinga Żelechowska-Matysiak, et al.
Published: (2023-03-01)